Cagrilintide + Samaglutide 10vials

Select variant

Research Applications

• Ingredients: Cagrilintide + Semaglutide co-blend
• Dual amylin + GLP-1 agonist research cocktail
• Designed for combination metabolic-pathway assays
• Two-peptide lyophilizate - ratios per SKU label

Description

Fixed research blend of cagrilintide (amylin analog) plus semaglutide (GLP-1 agonist; label spelling "Samaglutide"). Composition co-formulates both acylated peptides in one vial for dual satiety/incretin pathway studies; mg strengths follow SKU (5/10/20 mg class). For research use only. Not for human consumption.